Cancer risk linked to p53 in ulcerative colitis
Researchers in the lab of Michael Sigal at the Max Delbrück Center and Charité – Universitätsmedizin Berlin have elucidated the role of the p53 gene in ulcerative colitis. The study,…
Moderately to everely active Ulcerative Colitis, European Commission approves Pfizer’s etrasimod (Velsipity®)
Pfizer Inc. (NYSE: PFE) announced today that the European Commission (EC) has granted marketing authorization for VELSIPITY® (etrasimod) in the European Union to treat patients 16 years of age and…